You are here

Menarini Group

Member Since 2020

Elcin Barker Ergun

Chief Executive Officer

Elcin Barker Ergun worked in Global, Regional and Local leadership roles in Pharma Industry for more than 20 years including Commercial, Finance and Innovation leadership.

Elcin is Member of the Board of Directors and CEO of Menarini Group as of September 2019 based in Florence.

Prior to that, she was EVP, President of New Businesses, Merck KGaA Healthcare based in Boston responsible for an entity carrying out external R&D collaborations to create new businesses with estimated peak sales of $5-9billion.

Before that, she was EVP, Head of Global Commercial for Merck Serono based in Germany, where she was responsible for a P&L of €4.5 billion and over 5,000 people and achieved significant business and leadership transformation across global operations.

Prior to that, she was SVP, Head of Intercontinental Region comprising of 69 countries across Middle East, Africa, Turkey, Russia/CIS with a P&L of €650 million. During her term, topline grew by 40%. Prior to that, she was Managing Director of Turkey, where she started up and grew the operation to become a strong specialty player attaining market leadership in each key business.

In her earlier career, Elcin held several finance roles as subsidiary CFO Smithkline Beecham and as subsidiary CFO for Honeywell where she was responsible for full spectrum of finance, accounting, treasury, tax and reporting functions. She also spent one year in UK at Northern European HQ of Honeywell leading marketing and supply chain projects. She started her career as a software engineer and worked for ITT in Amsterdam for 5 years in IT Management.

Menarini Group

Menarini Group, the leading Italian pharmaceutical company in the world, has 17,640 employees in 136 countries, including the US in San Diego and Philadelphia.